Patents by Inventor Steven M. Yannone

Steven M. Yannone has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11015181
    Abstract: The present invention provides for a novel recombinant or isolated nucleic acid useful for integrating or being maintained in an Archaea or acidophilic hyperthermophilic eubacteria. The nucleic acid encodes a nucleotide sequence that is capable of stably integrating into the chromosome of a host cell, or being maintained as an extrachromosomal element in a host cell, that is an Archea, and a nucleotide sequence of interest. The present invention also provides for an Archaea host cell comprising the nucleic acid stably integrated into the chromosome or maintained episomally in the host cell, and a method of expressing the nucleotide sequence of interest in the host cell and/or directing glycosylation, multimerization, and/or membrane association or integration.
    Type: Grant
    Filed: August 20, 2018
    Date of Patent: May 25, 2021
    Assignee: The Regents of the University of California
    Inventors: Steven M. Yannone, Adam Barnebey
  • Publication number: 20190112562
    Abstract: The present disclosure relates to a composition for cleaning or sanitizing a surface, methods of using the same for cleaning and sanitizing a surface, and kits comprising the same. The composition includes an enzyme isolated from a hyperthermophilic and/or acidophilic organism and optionally, an acid and an additive. The composition can be used at temperatures ranging from about 50° C. to 110° C., preferably at temperatures ranging from about 70° C. to 100° C. In addition, the composition can be used at pH values ranging from 0.5 to 7, preferably at pH values ranging from 2 to 5.
    Type: Application
    Filed: April 6, 2017
    Publication date: April 18, 2019
    Applicant: Cinder Biological, Inc.
    Inventors: Steven M. Yannone, Jill O. Fuss, Adam Barnebey
  • Publication number: 20180355336
    Abstract: The present invention provides for a novel recombinant or isolated nucleic acid useful for integrating or being maintained in an Archaea or acidophilic hyperthermophilic eubacteria. The nucleic acid encodes a nucleotide sequence that is capable of stably integrating into the chromosome of a host cell, or being maintained as an extrachromosomal element in a host cell, that is an Archea, and a nucleotide sequence of interest. The present invention also provides for an Archaea host cell comprising the nucleic acid stably integrated into the chromosome or maintained episomally in the host cell, and a method of expressing the nucleotide sequence of interest in the host cell and/or directing glycosylation, multimerization, and/or membrane association or integration.
    Type: Application
    Filed: August 20, 2018
    Publication date: December 13, 2018
    Inventors: Steven M. Yannone, Adam Barnebey
  • Patent number: 10066223
    Abstract: The present invention provides for a novel recombinant or isolated nucleic acid useful for integrating or being maintained in an Archaea or acidophilic hyperthermophilic eubacteria. The nucleic acid encodes a nucleotide sequence that is capable of stably integrating into the chromosome of a host cell, or being maintained as an extrachromosomal element in a host cell, that is an Archea, and a nucleotide sequence of interest. The present invention also provides for an Archaea host cell comprising the nucleic acid stably integrated into the chromosome or maintained episomally in the host cell, and a method of expressing the nucleotide sequence of interest in the host cell and/or directing glycosylation, multimerization, and/or membrane association or integration.
    Type: Grant
    Filed: November 21, 2013
    Date of Patent: September 4, 2018
    Assignee: The Regents of the University of California
    Inventors: Steven M. Yannone, Adam Barnebey
  • Patent number: 9931634
    Abstract: Kits, methods and systems for providing a service to provide a subject with information regarding the state of a subject's DNA damage. Collection, processing and analysis of samples are also described.
    Type: Grant
    Filed: February 27, 2015
    Date of Patent: April 3, 2018
    Assignees: The Regents of the Univeristy of California, Exogen Biotechnology, Inc.
    Inventors: Sylvain V. Costes, Jonathan Tang, Steven M. Yannone
  • Publication number: 20160025709
    Abstract: Kits, methods and systems for providing a service to provide a subject with information regarding the state of a subject's DNA damage. Collection, processing and analysis of samples are also described.
    Type: Application
    Filed: February 27, 2015
    Publication date: January 28, 2016
    Inventors: Sylvain V. Costes, Jonathan Tang, Steven M. Yannone
  • Publication number: 20150291948
    Abstract: The present invention provides for a novel recombinant or isolated nucleic acid useful for integrating or being maintained in an Archaea or acidophilic hyperthermophilic eubacteria. The nucleic acid encodes a nucleotide sequence that is capable of stably integrating into the chromosome of a host cell, or being maintained as an extrachromosomal element in a host cell, that is an Archea, and a nucleotide sequence of interest. The present invention also provides for an Archaea host cell comprising the nucleic acid stably integrated into the chromosome or maintained episomally in the host cell, and a method of expressing the nucleotide sequence of interest in the host cell and/or directing glycosylation, multimerization, and/or membrane association or integration.
    Type: Application
    Filed: November 21, 2013
    Publication date: October 15, 2015
    Inventors: Steven M. Yannone, Adam Barnebey
  • Publication number: 20150017092
    Abstract: Systems and methods for determining the sensitivity of cells (and/or a subject) to ionizing radiation are provided. The systems can comprise a microfluidic device comprising a plurality of microfluidic cavities each configured to contain cells; a source of ionizing radiation configured to deliver ionizing radiation to cells in the microfluidic cavities; and an imaging system configured to detect radiation-induced foci in cells when they are disposed in the microfluidic cavities. The methods can involve contacting a biological sample comprising cells from a subject with ionizing radiation; detecting and quantifying radiation induced foci in the cells at least two different time points; and determining a repair kinetic for radiation induced foci that is a measure of the rate of disappearance of the foci. Methodologies are also provided for in-home blood collection and fixation of nucleated blood cells in a manner to preserve health and fitness biomarkers inherent to these cells.
    Type: Application
    Filed: March 14, 2013
    Publication date: January 15, 2015
    Inventors: Sylvain V. Costes, Rafael Gomez-Sjoberg, Steven M. Yannone